导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.65% | 517/1050 |
| 近一周 | 1.18% | 165/1104 |
| 近一月 | -2.84% | 510/1103 |
| 近一季 | -25.22% | 1049/1092 |
| 近半年 | 3.86% | 352/1070 |
| 近一年 | 6.12% | 453/1018 |
| 近两年 | 47.88% | 523/926 |
| 近三年 | 25.90% | 439/834 |
| 成立以来 | 381.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.35% 961/1070 |
63.47% 169/1101 |
- - |
- - |
| 2025 | 36.82% 370/1065 |
4.35% 455/1014 |
4.33% 338/1038 |
24.50% 453/1050 |
0.95% 407/1065 |
| 2024 | -4.93% 704/1011 |
3.85% 138/960 |
-0.47% 338/983 |
4.67% 894/991 |
-12.12% 959/1011 |
| 2023 | -16.34% 575/952 |
3.92% 378/880 |
-4.89% 514/895 |
-10.84% 615/915 |
-5.07% 515/952 |
| 2022 | -18.77% 290/867 |
-15.39% 280/773 |
16.29% 82/806 |
-15.07% 571/845 |
-2.80% 567/867 |
| 2021 | 19.79% 157/740 |
-10.73% 503/580 |
22.08% 128/659 |
4.16% 142/704 |
5.53% 205/740 |
| 2020 | 74.59% 118/554 |
2.52% 101/419 |
31.01% 113/466 |
6.34% 337/517 |
22.23% 99/554 |
| 2019 | 67.10% 49/410 |
40.12% 64/1149 |
-1.51% 484/1231 |
11.76% 85/390 |
8.34% 224/410 |
| 2018 | -32.48% 251/349 |
- - |
- - |
- - |
-12.80% 707/1080 |
| 2017 | 20.00% 81/285 |
- - |
- - |
- - |
- - |
| 2016 | -19.34% 115/205 |
- - |
- - |
- - |
- - |
| 2015 | 25.59% 51/151 |
- - |
- - |
- - |
- - |
| 2014 | 18.50% 14/24 |
- - |
- - |
- - |
- - |
| 2013 | 27.96% 6/21 |
- - |
- - |
- - |
- - |
| 2012 | 4.26% 95/157 |
- - |
- - |
- - |
- - |
| 2011 | -21.68% 45/102 |
- - |
- - |
- - |
- - |
| 2010 | -10.35% 22/58 |
- - |
- - |
- - |
- - |
| 2009 | 79.68% 19/27 |
- - |
- - |
- - |
- - |
| 2008 | -55.85% 9/26 |
- - |
- - |
- - |
- - |
| 2007 | 97.57% 20/22 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 宏利首选企业股票A VS. 东吴新产业精选股票A(580008) |